Adaptive Phage Therapeutics can take its therapy for superbugs to human trials.
Image: Dr. Carl Merril, third from right, with his son Greg, CEO and co-founder of Adaptive Phage Therapeutics, and other members of the team. ADAPTIVE PHAGE THERAPEUTICS INC.
{iframe}https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/washington/news/2020/03/19/gaithersburg-biotech-gets-green-light-for-superbug.amp.html{/iframe}